A drug used to reduce unusually high levels of blood cholesterol.
Oral agent for the treatment of hyperlipoproteinemia; the most common side effect involves asymptomatic changes in the patient’s liver tests.
An HMGCoA reductase inhibitor and lipid-lowering agent. It is administered orally, as an adjunct to diet and exercise, to manage hypercholesterolemia and mixed dyslipidemias.